Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.5614
-0.0207 (-3.56%)
Apr 29, 2026, 4:00 PM EDT - Market closed
Curis Employees
As of December 31, 2025, Curis had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 10 or -29.41% compared to the previous year.
Employees
24
Change (1Y)
-10
Growth (1Y)
-29.41%
Revenue / Employee
$393,458
Profits / Employee
-$315,917
Market Cap
22.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | -10 | -29.41% | 20 | 4 |
| Dec 31, 2024 | 34 | -15 | -30.61% | 33 | 1 |
| Dec 31, 2023 | 49 | -2 | -3.92% | 49 | 0 |
| Dec 31, 2022 | 51 | -9 | -15.00% | 51 | 0 |
| Dec 31, 2021 | 60 | 32 | 114.29% | 60 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| Quince Therapeutics | 38 |
| OSR Holdings | 22 |
| Barinthus Biotherapeutics | 14 |
| Serina Therapeutics | 13 |
| VYNE Therapeutics | 10 |
| Exicure | 8 |
| Allarity Therapeutics | 8 |
CRIS News
- 5 weeks ago - Curis Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Curis Provides Fourth Quarter 2025 Business Update - PRNewsWire
- 6 weeks ago - Curis Transcript: EGM 2026 - Transcripts
- 6 weeks ago - Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026 - PRNewsWire
- 3 months ago - Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - PRNewsWire
- 4 months ago - Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - PRNewsWire
- 5 months ago - Curis Provides Updated Data from its Frontline AML Triplet Study - PRNewsWire
- 5 months ago - Curis to Present at Upcoming 30th Annual SNO Meeting - PRNewsWire